Triheptanoin

Category: Genetic Disorders



Triheptanoin Overview

Triheptanoin, sold under the brand name Dojolvi, is a medication for the treatment of children and adults with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD).[1][2] The most common adverse reactions include abdominal pain, diarrhea, vomiting, and nausea.[1][2] Triheptanoin was approved for medical use in the United States in June 2020.[3][2] Triheptanoin is a triglyceride...

Read more Triheptanoin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Triheptanoin

Recent Triheptanoin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Triheptanoin
  • Liquid: 100% W/w, 35%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Triheptanoin or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 August 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA